New search | Conferencedetail
mail
Print view
 
 

12th World Clinical Biomarkers and CDx Summit

Evvnt Promotion / evvnt
-
28.09.2022 - 29.09.2022  The Westin Boston Seaport District, 425 Summer Street, 02210 Boston, USA
Time: 6:50 am to 4:35 pm
 
Conference themes
The 12th World Clinical Biomarkers and CDx Summit returns at a crucial time for the entire precision and targeted drug development industry. Spurred on by a number of recent exciting biomarker-driven therapy and CDx approvals by the FDA, including Eli Lilly's Verzenio, J&J's Amivantamab and Takeda's Mobocertinib, the race to market is becoming ever fiercer to deliver the next-generation of safer and more effective therapies for defined patient populations.
Scientific Society
Hanson Wade
Notes
Speakers: Aaron Schetter, Senior Director, Regulatory Affairs, Companion Diagnostics, Daiichi Sankyo, Inc., Amy Gorman, Director, Global Commercial Strategy, Precision Medicine, Janssen, Antonio Chambers, Associate Director, Technical Diagnostic Test
 

Enquiries and Registration:

https://go.evvnt.com/1145208-2?pid=4832
Ms. Anita Kelemen
 
Categories
General Medicine, Medical and Chemical Laboratory Diagnostics
Languages
English
Congress fees
Free: USD 0.00
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

Hilfswerk AustriaAGEM - Arbeitsgemeinschaft Ethnologie und MedizinSwiss Tropical and Public Health InstituteÄrztekammer für WienÖsterreichisches Rotes KreuzCharité International AcademyAlumni Club Medizinische Universität WienEuropean Health Forum Gastein